TerminologyThis is the Continuous Integration Build of FHIR (will be incorrect/inconsistent at times).
See the Directory of published versions
| Responsible Owner: Biomedical Research and Regulation Work Group | Standards Status: Informative |
Raw XML (canonical form + also see XML Format Specification)
Definition for Code SystemOligoNucleotideTypeExample
<?xml version="1.0" encoding="UTF-8"?> <CodeSystem xmlns="http://hl7.org/fhir"> <id value="oligo-nucleotide-type"/> <meta> <lastUpdated value="2026-06-23T16:20:19.822+00:00"/> </meta> <text> <status value="generated"/> <div xmlns="http://www.w3.org/1999/xhtml"> <p class="res-header-id"> <b> Generated Narrative: CodeSystem oligo-nucleotide-type</b> </p> <a name="oligo-nucleotide-type"> </a> <a name="hcoligo-nucleotide-type"> </a> <p> This case-sensitive code system <code> http://hl7.org/fhir/oligo-nucleotide-type</code> defines the following codes: </p> <table class="codes"> <tr> <td style="white-space:nowrap"> <b> Code</b> </td> <td> <b> Display</b> </td> <td> <b> Definition</b> </td> </tr> <tr> <td style="white-space:nowrap">antisense <a name="oligo-nucleotide-type-antisense"> </a> </td> <td> Antisense oligonucleotide</td> <td> An antisense oligonucleotide (ASO) that binds to a complementary mRNA sequence to inhibit gene expression.</td> </tr> <tr> <td style="white-space:nowrap">sirna <a name="oligo-nucleotide-type-sirna"> </a> </td> <td> Small interfering RNA (siRNA)</td> <td> A short double-stranded RNA that triggers degradation of a target mRNA through the RNA interference pathway.</td> </tr> <tr> <td style="white-space:nowrap">mirna <a name="oligo-nucleotide-type-mirna"> </a> </td> <td> MicroRNA (miRNA)</td> <td> A short non-coding RNA that regulates gene expression by base-pairing with target mRNAs.</td> </tr> <tr> <td style="white-space:nowrap">aptamer <a name="oligo-nucleotide-type-aptamer"> </a> </td> <td> Aptamer</td> <td> A short single-stranded oligonucleotide that binds a specific target through its three-dimensional structure.</td> </tr> <tr> <td style="white-space:nowrap">decoy <a name="oligo-nucleotide-type-decoy"> </a> </td> <td> Decoy oligonucleotide</td> <td> An oligonucleotide that mimics a regulatory binding site to sequester a transcription factor or other binding protein.</td> </tr> <tr> <td style="white-space:nowrap">ribozyme <a name="oligo-nucleotide-type-ribozyme"> </a> </td> <td> Ribozyme / DNAzyme</td> <td> A catalytic oligonucleotide capable of cleaving a target nucleic acid.</td> </tr> <tr> <td style="white-space:nowrap">gene-fragment <a name="oligo-nucleotide-type-gene-fragment"> </a> </td> <td> Gene fragment</td> <td> A fragment of a gene such as a promoter, enhancer, coding region or silencer.</td> </tr> </table> </div> </text> <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-wg"> <valueCode value="brr"/> </extension> <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status"> <valueCode value="informative"/> </extension> <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm"> <valueInteger value="1"/> </extension> <url value="http://hl7.org/fhir/oligo-nucleotide-type"/> <version value="6.0.0-ballot4"/> <name value="OligoNucleotideTypeExample"/> <title value="Oligonucleotide Type"/> <status value="active"/> <experimental value="true"/> <date value="2026-06-21"/> <publisher value="HL7 (FHIR Project)"/> <contact> <telecom> <system value="url"/> <value value="http://hl7.org/fhir"/> </telecom> <telecom> <system value="email"/> <value value="fhir@lists.hl7.org"/> </telecom> </contact> <description value="The class of oligonucleotide, where relevant (e.g. antisense, siRNA, aptamer)."/> <jurisdiction> <coding> <system value="http://unstats.un.org/unsd/methods/m49/m49.htm"/> <code value="001"/> <display value="World"/> </coding> </jurisdiction> <caseSensitive value="true"/> <valueSet value="http://hl7.org/fhir/ValueSet/oligo-nucleotide-type"/> <content value="complete"/> <concept> <code value="antisense"/> <display value="Antisense oligonucleotide"/> <definition value="An antisense oligonucleotide (ASO) that binds to a complementary mRNA sequence to inhibit gene expression."/> </concept> <concept> <code value="sirna"/> <display value="Small interfering RNA (siRNA)"/> <definition value="A short double-stranded RNA that triggers degradation of a target mRNA through the RNA interference pathway."/> </concept> <concept> <code value="mirna"/> <display value="MicroRNA (miRNA)"/> <definition value="A short non-coding RNA that regulates gene expression by base-pairing with target mRNAs."/> </concept> <concept> <code value="aptamer"/> <display value="Aptamer"/> <definition value="A short single-stranded oligonucleotide that binds a specific target through its three-dimensional structure."/> </concept> <concept> <code value="decoy"/> <display value="Decoy oligonucleotide"/> <definition value="An oligonucleotide that mimics a regulatory binding site to sequester a transcription factor or other binding protein."/> </concept> <concept> <code value="ribozyme"/> <display value="Ribozyme / DNAzyme"/> <definition value="A catalytic oligonucleotide capable of cleaving a target nucleic acid."/> </concept> <concept> <code value="gene-fragment"/> <display value="Gene fragment"/> <definition value="A fragment of a gene such as a promoter, enhancer, coding region or silencer."/> </concept> </CodeSystem>
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.
FHIR ®© HL7.org 2011+. FHIR R6 hl7.fhir.r6.core#6.0.0-ballot4 generated on Tue, Jun 23, 2026 16:22+0000.
Links: Search |
Version History |
Contents |
Glossary |
QA |
Compare to R4 |
Compare to R5 |
Compare to Last Ballot |
|
Propose a change